(Q38119018)

29 August 2017

title

Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension (English)

1 reference

29 August 2017

0 references

arterial hypertension

0 references

3

Mark T Gladwin

1 reference

29 August 2017

James R Klinger

1

1 reference

29 August 2017

Steven H Abman

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 September 2013

1 reference

American Journal of Respiratory and Critical Care Medicine

29 August 2017

published in

1 reference

29 August 2017

volume

188

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

639-646

1 reference

Nitric oxide synthases: structure, function and inhibition

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Arginine de novo and nitric oxide production in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Requirement of argininosuccinate lyase for systemic nitric oxide production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

L-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

S-glutathionylation uncouples eNOS and regulates its cellular and vascular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Nitrite signaling in pulmonary hypertension: mechanisms of bioactivation, signaling, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Differential expression of PDE5 in failing and nonfailing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Soluble guanylyl cyclase during postnatal porcine pulmonary maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0686PP

10.1164/RCCM.201304-0686PP

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference